PHS
LNTH icon

PFM Health Sciences’s Lantheus LNTH Stock Holding History

PFM Health Sciences’s Portfolio LNTH Stock Details LNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
+146,403
New +$13.6M 1.39% 22
2023
Q4 		– Sell
-372,761
Closed -$25.9M – 73
2023
Q3 		$25.9M Buy
+372,761
New +$27.3M 1.22% 36

Other funds holding LNTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's LNTH Position: Q2 2026 in Review

PFM Health Sciences opened a new position in Lantheus (LNTH) in Q2 2026: 146,403 shares worth $16.2M. The stake represents 1.39% of the portfolio and ranks #22 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in LNTH as recently as Q3 2023.

PFM Health Sciences first reported a position in LNTH in Q3 2023 and has held it in 2 quarters since. The position peaked at $25.9M in Q3 2023. 466 funds tracked by Wall St. Rank hold LNTH as of Q2 2026.

  • PFM Health Sciences held 146,403 shares of Lantheus worth $16.2M as of Q2 2026.
  • Lantheus was a new PFM Health Sciences position in Q2 2026.
  • Lantheus made up 1.39% of PFM Health Sciences's portfolio in Q2 2026, its #22 holding.
  • PFM Health Sciences first reported a position in Lantheus in Q3 2023 and has held it in 2 quarters since.
  • PFM Health Sciences's Lantheus position peaked at $25.9M in Q3 2023.
  • 466 funds tracked by Wall St. Rank held Lantheus as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.